pregabalin
Generic: pregabalin
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
pregabalin
Generic Name
pregabalin
Labeler
asclemed usa, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
pregabalin 25 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-095
Product ID
76420-095_ead3b1c9-5c7d-457b-e053-2995a90a71ef
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208677
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2019-07-19
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420095
Hyphenated Format
76420-095
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pregabalin (source: ndc)
Generic Name
pregabalin (source: ndc)
Application Number
ANDA208677 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (76420-095-30)
- 60 CAPSULE in 1 BOTTLE (76420-095-60)
- 90 CAPSULE in 1 BOTTLE (76420-095-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ead3b1c9-5c7d-457b-e053-2995a90a71ef", "openfda": {"unii": ["55JG375S6M"], "rxcui": ["483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127"], "spl_set_id": ["3d2464fb-b3ac-496e-b8a5-c2e8a902ce29"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-095-30)", "package_ndc": "76420-095-30", "marketing_start_date": "20200617"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-095-60)", "package_ndc": "76420-095-60", "marketing_start_date": "20200617"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-095-90)", "package_ndc": "76420-095-90", "marketing_start_date": "20200617"}], "brand_name": "Pregabalin", "product_id": "76420-095_ead3b1c9-5c7d-457b-e053-2995a90a71ef", "dosage_form": "CAPSULE", "product_ndc": "76420-095", "dea_schedule": "CV", "generic_name": "PREGABALIN", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pregabalin", "active_ingredients": [{"name": "PREGABALIN", "strength": "25 mg/1"}], "application_number": "ANDA208677", "marketing_category": "ANDA", "marketing_start_date": "20190719", "listing_expiration_date": "20261231"}